Sec Form 5 Filing - DERMASTAR INTERNATIONAL, LLC @ Imprimis Pharmaceuticals, Inc. - 2012-12-31

FORM 5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person DERMASTAR INTERNATIONAL, LLC 2. Issuer Name and Ticker or Trading Symbol Imprimis Pharmaceuticals, Inc. [ IMMY] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 1302 WAUGH DRIVE, STE 618 3. Date of Earliest Transaction (MM/DD/YY) 12/31/2012 (Street) HOUSTON, TX77019 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/28/2012 C( 2 ) 1,454,962 A $ 0 0 ( 1 ) D Common Stock 04/30/2012 J( 3 ) 193,047 A $ 762,534 0 ( 1 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Convertible Debenture $ 0.6668 01/01/2012 P 856,087 02/28/2012 04/05/2012 Common Stock 1,454,962 $ 50,000 0 D Convertible Debenture $ 0.6668 02/28/2012 C 856,087 02/28/2012 04/05/2012 Common Stock 1,454,962 $ 0 0 ( 1 ) D Warrants $ 5.925 04/30/2012 P 48,262 04/30/2012 04/29/2015 Common Stock 48,262 $ 0 0 ( 1 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other DERMASTAR INTERNATIONAL, LLC 1302 WAUGH DRIVE STE 618 HOUSTON, TX77019 X Signatures /s/ Mark Baum 03/15/2013 Signature of Reporting Person Date

Explanation of Responses:

( 1 )As previously reported on a Form 4 filed on July 20, 2012, on July 12, 2012, the reporting person distributed to its members all securities of the Issuer held by it and was subsequently dissolved. ( 2 )Represents the shares of common stock acquired by the reporting person upon automatic conversion of a convertible debenture issued by the Issuer on April 5, 2010 and acquired from the initial holder by the reporting person in a private transaction on January 1, 2012. ( 3 )Represents shares received upon the exchange of amounts owing under an outstanding Line of Credit into common stock of the Issuer.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.